The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation

REFERENCES

1. 1.↵
   Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdf.
2. 2.↵
   1. Seemungal TA,
   2. Hurst JR,
   3. Wedzicha JA

   . Exacerbation rate, health status and mortality in COPD: a review of potential interventions. Int J Chron Obstruct Pulmon Dis 2009;4:203–223.

   OpenUrlPubMed
3. 3.↵
   1. Koutsokera A,
   2. Stolz D,
   3. Loukides S,
   4. Kostikas K

   . Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest 2012;141(2):396–405.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Weyrich AS,
   2. Lindemann S,
   3. Zimmerman GA

   . The evolving role of platelets in inflammation. J Thromb Haemost 2003;1(9):1897–1905.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Merolla M,
   2. Nardi MA,
   3. Hu L,
   4. Rockman CB,
   5. Berger JS

   . Platelet size is an excellent surrogate for increased platelet activity. J Am Coll Cardiol 2011;57(14):E1600.

   OpenUrlCrossRef
6. 6.↵
   1. Bancroft AJ,
   2. Abel EW,
   3. Mclaren M,
   4. Belch JJ

   . Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000;11(7):379–387.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Dastjerdi MS,
   2. Emami T,
   3. Najafian A,
   4. Amini M

   . Mean platelet volume measurement, EDTA or citrate? Hematology 2006;11(5):317–319.

   OpenUrlCrossRefWeb of Science
8. 8.↵
   1. Biljak VR,
   2. Pancirov D,
   3. Cepelak I,
   4. Popović-Grle S,
   5. Stjepanović G,
   6. Grubišić TŽ

   . Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011;22(6):466–470.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Steiropoulos P,
   2. Papanas N,
   3. Nena E,
   4. Xanthoudaki M,
   5. Goula T,
   6. Froudarakis M,
   7. et al

   . Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology 2013;64(7):535–539.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Ulasli SS,
    2. Ozyurek BA,
    3. Yilmaz EB,
    4. Ulubay G

    . Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn 2012;122(6):284–290.

    OpenUrlPubMed
11. 11.↵
    1. Wang RT,
    2. Li JY,
    3. Cao ZG,
    4. Li Y

    . Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology 2013;18(8):1244–1248.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Erden ES,
    2. Dokuyucu R,
    3. Demirköse M,
    4. Yengil E,
    5. Sefil F,
    6. Bilgiç HK,
    7. et al

    . Assessment of mean platelet volume in chronic obstructive pulmonary disease during stable period and acute exacerbation. J Clin Exp Invest 2013;4(4):483–487.

    OpenUrl
13. 13.↵
    1. Bathoorn E,
    2. Liesker JJ,
    3. Postma DS,
    4. Koëter GH,
    5. van der Toorn M,
    6. van der Heide S,
    7. Kerstjens HA

    . Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis 2009;4:101–109.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Wouters EF

    . Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2(1):26–33.

    OpenUrlPubMed
15. 15.↵
    1. Wedzicha JA,
    2. Seemungal TA,
    3. MacCallum PK,
    4. Paul EA,
    5. Donaldson GC,
    6. Bhowmik A,
    7. et al

    . Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000;84(2):210–215.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Hurst JR,
    2. Donaldson GC,
    3. Perera WR,
    4. Wilkinson TM,
    5. Bilello JA,
    6. Hagan GW,
    7. et al

    . Utility of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(8):867–874.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Gan WQ,
    2. Man SF,
    3. Senthilselvan A,
    4. Sin DD

    . Association between chronic obstructive pulmonary disease and systemic inflammation: a systemic review and a meta-analysis. Thorax 2004;59(7):574–580.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Barnes PJ,
    2. Celli BR

    . Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165–1185.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Polosa R,
    2. Malerba M,
    3. Cacciola RR,
    4. Morjaria JB,
    5. Maugeri C,
    6. Prosperini G,
    7. et al

    . Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. Intern Emerg Med 2013;8(7):567–574.

    OpenUrlPubMed
20. 20.↵
    1. Maclay JD,
    2. McAllister DA,
    3. Johnston S,
    4. Raftis J,
    5. McGuinnes C,
    6. Deans A,
    7. et al

    . Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011;66(9):769–774.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Gasparyan AY,
    2. Ayvazyan L,
    3. Mikhailidis DP,
    4. Kitas GD

    . Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17(1):47–58.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Papi A,
    2. Bellettato CM,
    3. Braccioni F,
    4. Romagnoli M,
    5. Casolari P,
    6. Caramori G,
    7. et al

    . Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173(10):1114–1121.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Agapakis DI,
    2. Tsantilas D,
    3. Psarris P,
    4. Massa EV,
    5. Kotsaftis P,
    6. Tziomalos K,
    7. Hatzitolios AI

    . Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology 2010;15(5):796–803.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Uysal P,
    2. Tuncel T,
    3. Olmez D,
    4. Babayigit A,
    5. Karaman O,
    6. Uzuner N

    . The role of mean platelet volume predicting acute exacerbations of cystic fibrosis in children. Ann Thorac Med 2011;6(4):227–230.

    OpenUrlPubMed
25. 25.↵
    1. Sun WX,
    2. Zhang JR,
    3. Cao ZG,
    4. Li Y,
    5. Wang RT

    . A decreased mean platelet volume is associated with stable and exacerbated asthma. Respiration 2014;88(1):31–37.

    OpenUrlPubMed